- €17.59m
- €16.00m
- €8.13m
- 49
- 57
- 23
- 36
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
Standards: | FAS | FAS | FAS | FAS |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 16.6 | 13.6 | 10.8 | 8.13 |
Selling / General / Administrative Expenses | ||||
Depreciation and Amortization | ||||
Unusual Expense / Income | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 15.7 | 11 | 9.17 | 3.38 |
Operating Profit | 0.851 | 2.58 | 1.63 | 4.75 |
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | 0.676 | 2.42 | 1.48 | 4.74 |
Provision for Income Taxes | ||||
Net Income After Taxes | 0.513 | 1.72 | 1.08 | 3.49 |
Net Income Before Extraordinary Items | ||||
Net Income | 0.513 | 1.72 | 1.08 | 3.49 |
Adjustments to Net Income | ||||
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | 0.513 | 1.72 | 1.08 | 3.49 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | 0.645 | 0.335 | 0.258 | 0.204 |